Real-Life Study in Diabetic Macular Edema

Kocaeli University

Status: Completed

Conditions: Diabetic Macular Edema

Treatments: Other: Retrospective study

Study type: Observational

Funder types: Other

Identifiers

NCT05472376

MARMASIA Study Group

Details and patient eligibility

About

The goal of this study is to evaluate the real-world outcomes of intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment in diabetic macular edema (DME) patients.

Full description

The study included patients who were being observed in the retina departments of 8 tertiary hospitals in the Northern Marmara Region of Turkey (Istanbul's Asian Side, Kocaeli, and Sakarya). The records of DME patients treated with an anti-VEGF agent between January 2015 and December 2018 were reviewed.

Enrollment: 854 patients

Sex

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diabetic macular edema treated with intravitreal anti-VEGF injection
• Having at least 4 or more annual examination visits

Exclusion criteria

• Phacoemulsification surgery in the last 1 month
• PRFK / grid / focal / micropulse in the last 4 months
• Previous intraocular surgery (excluding PPV and phacoemulsification)

Trial design

854 participants in 5 patient groups

3-month follow-up

Treatment:

Other: Retrospective study

6-month follow-up

Treatment:

Other: Retrospective study

12-month follow-up

Treatment:

Other: Retrospective study

24-month follow-up

Treatment:

Other: Retrospective study

36-month follow-up

Treatment:

Other: Retrospective study